• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

Aims The effect of atrial fibrillation catheter ablation on cardiovascular outcomes in heart
failure is an important outstanding research question. We undertook a meta-analysis of …

In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

Background Little is known about the very long term durability of atrial fibrillation (AF)
ablation. Objective The purpose of this study was to evaluate very long term AF ablation …

Background Atrial fibrillation (AF) is common in heart failure (HF), is associated with worse
outcomes compared with sinus rhythm, and may modify the effects of therapy. Objectives …

Background Age is a relevant risk factor for the development of atrial fibrillation (AF) and is
associated with increased recurrence rates in the setting of rhythm-control. Catheter ablation …

Background The results of studies comparing the outcomes of catheter ablation (CA) to
those of medical therapy (MT) for atrial fibrillation (AF) in heart failure (HF) patients are …

Atrial fibrillation is the most common atrial arrhythmia and accounts for a significant burden
of cardiovascular disease globally. With advances in implanted and wearable cardiac …